Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

NCT02598219 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

262

Enrollment

OTHER

Sponsor class

Conditions

Non Endometrioid Carcinoma
Endometrioid Carcinoma

Interventions

DRUG: Pre-operative SN mapping with radionucleide
DRUG: Intra-operative SN mapping with patent V blue dye
DRUG: Intra-operative SN mapping with indocyanin green
PROCEDURE: Full bilateral laparoscopic lymphadenectomy and Hysterectomy
PROCEDURE: Current initial staging protocols

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]
[object Object]
[object Object]